U.S. secures 600,000 more doses of GSK-Vir's COVID-19 therapy
Go back to U.S. secures 600,000 more doses of GSK-Vir's COVID-19 therapy| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.07 +0.29 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.78 | 52 Week High | $45.58 | |||
| Open | $51.57 | 52 Week Low | $37.82 | |||
| Day High | $52.21 | P/E | N/A | |||
| Day Low | $51.51 | EPS | $0.00 | |||
| Volume | 2,699,125 | |||||
| (NASDAQ: VIR) | Delayed: 10.71 +0.80 (8.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.91 | 52 Week High | $ | |||
| Open | $10.03 | 52 Week Low | $ | |||
| Day High | $11.28 | P/E | N/A | |||
| Day Low | $9.97 | EPS | $ | |||
| Volume | 2,961,266 | |||||
